VarCov Co’s CONMED CNMD Stock Holding History

VarCov Co’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-24,805	Closed	-$1.01M	–	417
2025 Q4	$1.01M	Buy	+24,805	New	+$1.08M	0.4%	58

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

VarCov Co's CNMD Position: Q1 2026 in Review

VarCov Co sold out of CONMED (CNMD) in Q1 2026, closing a stake of 24,805 shares — an estimated $1.01M sold.

VarCov Co first reported a position in CNMD in Q4 2025 and held it in 1 quarter. The position peaked at $1.01M in Q4 2025. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

VarCov Co reported no remaining CONMED position as of Q1 2026 after selling out during the quarter.
VarCov Co sold 24,805 CONMED shares in Q1 2026, an estimated $1.01M.
VarCov Co first reported a position in CONMED in Q4 2025 and held it in 1 quarter.
VarCov Co's CONMED position peaked at $1.01M in Q4 2025.
236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on VarCov Co's 13F filing for Q1 2026, filed 15 May 2026.